您现在位置:健康网-医药产业 >> 研究报告 >> English reports >> English reports >> 浏览医药行业研究报告
健康网讯:
Research Report on Chinese Anticancer Drugs Market Publisher: Orient Health Electronic Commercial(Beijing)co.,Ltd Published: Format: Hardcopy and Adobe PDF Price: US$3,100 Contact: Mr. Bian chenghua Ms. Wu huifang Tel.: 86-10-68012929-2116/2101 Fax: 86-10-68012929-2008 E-mail: bianch@healthoo.com wuhf@healthoo.com http://www.healthoo.com Table of contents 1 Categories and action mechanism of anticancer drugs 1.1 Categories of main anticancer drugs 1.2 Summary of action mechanism 2 Market analysis of anticancer drugs 2.1 Market scale and growth trend 2.1.1 Theoretical market scale 2.1.2 Growth trend 2.2 Market shares of different categories 2.3 Market shares of different breeds 2.4 Leading manufacturing enterprises and sales value 2.5 Prospect of main breeds 2.6 Market shares of joint venture, foreign, joint venture enterprises 3 Sales analysis of representative anticancer drugs 3.1 Alkylating agent Ifosfamide Nitrosoureas 3.2 Anticancer antibiotics Epirubicin Pirarubicin Mitomycin Doxorubicin 3.3 Antimetabolites Gemcitabine Capecitabine Doxifluridine cytosine arabinoside 3.4 plant-originated anticancer drugs Paclitaxel Docetaxel Vinorelbine hydroxycamptothecin 3.5 Hormone Agent Triptorelin Flutamide Leuprorelin Toremifene Anastrozole Tamoxifen Goserelin 3.6 Platinum agent Oxaliplatin 3.7 Others Rituximab(Rituxan) Imatinib(Gleevec) 4 Sales analysis of non-representative anticancer drugs Immune Regulators of Chinese traditional medicine Chines traditional medicine with anticancer action Pamidronate Disodium
|